APBI Proton Feasibility and Phase II Study
A Feasibility And Phase Ii Trial Of Accelerated Partial Breast Irradiation Using Proton Therapy For Women With Stage IA-IIA Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
A PHASE1/PHASE2 clinical study on Stage IA-IIA Breast Cancer, this trial is completed. The trial is conducted by Abramson Cancer Center at Penn Medicine and has accumulated 13 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE1/PHASE2
Phase: NA → PHASE1/PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
May 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Jul 2022 — May 2023 [monthly]
Active Not Recruiting NA
-
May 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2019 — May 2020 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .